January 10, 2014 / 2:05 PM / 4 years ago

BRIEF-Chelsea Therapeutics down 27.8 percent premarket

NEW YORK, Jan 10 (Reuters) - Chelsea Therapeutics International Ltd : * Down 27.8 percent to $2.55 in premarket after FDA staff comments on droxidopa drug

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below